Skip to main content
OpenTrials

Clinical trial condition

Wild-Type Transthyretin Cardiac Amyloidosis

Explore clinical trials studying Wild-Type Transthyretin Cardiac Amyloidosis. Study availability and eligibility vary by location and protocol.

3 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Wild-Type Transthyretin Cardiac Amyloidosis trial results

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)

NCT04601051

Conditions
Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +19 more
Locations
  • Clinical Trial Site Paris, France
  • Clinical Trial Site Auckland, New Zealand
  • Clinical Trial Site Umeå, Sweden
  • Clinical Trial Site London, United Kingdom
View Trial Details

Related conditions